Dergiler / Bakırköy Tıp Dergisi / 2019 / Cilt: 15 - Sayı: 1

Serum Resistin Levels in Prediabetic Individuals

Prediyabetik Bireylerin Serum Rezistin Seviyeleri

Sayfa
47–54
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The onset or progression of diabetes could be slowed down by interveining the metabolic and modifiable parameters in prediabetic patients who have high risk of developing diabetes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: In this study we aimed to investigate the relationship between insulin resistance and pre-diabetic patients’ serum resistin levels, inflammatory and oxidative stress parameters that take part in the progress of type 2 diabetes mellitus (DM).
📊
Temel Bulgular & Veri:Methods: 59 adult patients who applied to the internal medicine out patient clinic were enrolled to the study [41 IFG (impaired fasting glucose), 18 IFG+IGT (impaired fasting glucose+impaired gluose tolerance)].
💡
Sonuç & Katkı:Conclusion: The onset or progression of diabetes could be slowed down by interveining the metabolic and modifiable parameters in prediabetic patients who have high risk of developing diabetes.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: In this study we aimed to investigate the relationship between insulin resistance and pre-diabetic patients’ serum resistin levels, inflammatory and oxidative stress parameters that take part in the progress of type 2 diabetes mellitus (DM). Resistin is a newly discovered adipokine which is secreted from adipose tissue that has important roles in the pathogenesis of obesity mediated-insulin resistance. Methods: 59 adult patients who applied to the internal medicine out patient clinic were enrolled to the study [41 IFG (impaired fasting glucose), 18 IFG+IGT (impaired fasting glucose+impaired gluose tolerance)]. Routine biochemical and haematological parameters were calculated by autoanalyzers. Serum resistin levels were measured by ELISA procedure. Statistical analyses were performed by SPSS for Windows. Results: Resistin levels in IFG and IFG+IGT groups were significantly higher compared to control group. A positive correlation were detected between serum resistin levels and age, FPG, HbA1C, Homa-IR, oral glucose tolerance test (OGTT) 0. hour, OGTT 2. hour also, there were a negative correlation between serum resistin levels and high-density lipoprotein. Conclusion: The onset or progression of diabetes could be slowed down by interveining the metabolic and modifiable parameters in prediabetic patients who have high risk of developing diabetes.

Abstract

Amaç: Biz bu çalışmamızda tip 2 diabetes mellitus (DM) gelişiminde rol aldığı öne sürülen nflamasyon, oksidatif stres ve insülin direncini gösteren parametrelerin prediyabetik dönemdeki düzeylerinin, serum rezistin düzeyi ile olan ilişkisini araştırmayı amaçladık. Yöntemler: Rezistin; son yıllarda keşfedilmiş, yağ dokusundan salgılanan adipokindir. Son dönemde yapılan çalışmalar obeziteyle ilişkili insulin direncinde önemli rolünün olduğunu göstermiştir. Çalışmamıza Ankara Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi Dahiliye polikliniklerine Temmuz 2012 ve Ekim 2012 tarihleri arasında genel muayene için başvuran, çalışma kriterlerine uyan 59 prediyabetik (41 BAG ve 18 BAG+BGT‘li) hasta dahil edilmiştir. Laboratuvar ölçümleri oto analizörlerde, serum rezistin düzeyleri ise ELISA kiti ile ölçülmüştür. Istatistiksel analizler SPSS programında yapılmıştır. Bulgular: Prediyabetik hasta gruplarında serum rezistin düzeyi kontrol grubuna göre anlamlı yüksek bulunmuştur. Çalışmamızda yaş, AKŞ, HbA1c, Homa-IR, oral glikoz tolerans testi (OGGT) 0. saat ve OGGT 2. saat ile rezistin arasında istatistiksel olarak anlamlı pozitif korelasyon görülürken, yüksek yoğunluklu lipoprotein ile rezistin arasında istatistiksel olarak anlamlı negatif korelasyon bulunmuştur Sonuç: Bu çalışma DM gelişme riski yüksek olan prediyabetik hastalarda metabolik parametrelerin ortaya çıkarılmasının ve değiştirilebilir parametrelere müdahale edilmesinin, diyabete ilerleyişin yavaşlatılmasını sağlayabileceğini serum rezistin seviyeleri değerlendirilerek ortaya koymuştur.

🔖

Bu Makaleye Atıf Yap

BİLGETEKİN, İ., GÖNDEREN, K., ÜSTÜNSOY, S., YILDIZ, M. Z. (2019). Serum Resistin Levels in Prediabetic Individuals. Bakırköy Tıp Dergisi, Cilt: 15 - Sayı: 1, 47–54. https://ajindex.com/articles/125702

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinology and Metabolism 2002;13:18-23.
  2. Wiecek A, Kokot F, Chudek J,Adamczak M. The adipose tissue- a novel endocrine organ of interest to the nephrologist. Nefrol Dial Transplant 2002;17:191-5. Berger A. Resistin: a new hormone that links obesity with type 2 diabetes, BMJ 2001;322:193. Uysal KT, Wiesbrock SM, Marino MW, Hotamısligil GS. Protection from obesity- induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-4.
  3. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005;111:932-9.
  4. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys Res Commun 2004;314:415-9.
  5. Reilly MP, Lerkhe M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005;111:932-9.
  6. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.
  7. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, et al. resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 2003;88:4848-56.
  8. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochemical Biophysical Research Communications 2001;285:561-4.
  9. Hui-bing H, Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, et al. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metabolism 2006;55:1670-3.
  10. Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2007;67:215-25.
  11. Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance, Metabolism Clinical and Experimental 2006,55:1495-9. D